Researchers from the Colour and Food Quality group at the Faculty of Pharmacy (University of Seville), in collaboration with ...

Cassava and former executives were charged Thursday by the SEC with making misleading claims in 2020 about trials for the ...

The Securities and Exchange Commission alleged that a researcher for the company manipulated trial data to make its drug ...

After decades of stagnation in the schizophrenia field, Bristol Myers Squibb’s $14 billion deal for Karuna Therapeutics has ...

Arizonans will be casting their ballots very soon and that might include individuals living with Alzheimer’s disease or some ...

The Shark Tank investor kept her mom's diagnosis a secret until she could evaluate her own risk of Alzheimer's. She's finally ...

WASHINGTON (Reuters) -Shares of Cassava Sciences fell 10% in post-market trading on Thursday after the U.S. Securities and ...

West Texas A&M Officials and state leaders are looking to advance the Panhandle Plains Historical Museum (PPHM) and Pioneer ...

The Securities and Exchange Commission today announced Cassava Sciences, Inc., its founder and former CEO, Remi Barbier, and its former Senior Vice President of Neuroscience, Dr. Lindsay Burns, will ...

Bristol Myers Squibb is exploring Cobenfy for Alzheimer’s-related psychosis, which has no approved treatment, among other ...

Cassava Sciences and two former executives will pay more than $40 million to settle charges related to misleading statements made about a clinical trial for the company's purported therapeutic ...

TOPEKA, Kan. (WIBW) - People will join in the fight against Alzheimer’s Disease this Saturday, when the annual Walk to End Alzheimer’s steps off in Topeka. Margaret Haden visited Eye on NE Kansas to ...